Oligonucleotide conjugates
Patent 4650675 Issued on March 17, 1987. Estimated Expiration Date: 
March 17, 2004. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
March 17, 2004. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References 3725545 3821193 Process for the production of vaccine Pharmaceutical composition comprising modified polyriboinosinic-polyribocytidylic acid, for induction of interferon in primates Tobramycin-double stranded RNA complex suitable for inducing interferon Vaccinal complex containing a specific antigen and vaccine containing it Propranolol immunogen and antibodies Patent #: 4472301 InventorsAssigneeApplicationNo. 06/524298 filed on 08/18/1983US Classes:424/179.1, Conjugated via claimed linking group, bond, chelating agent, or coupling agent (e.g., conjugated to proteinaceous toxin via claimed linking group, bond, coupling agent, etc.)424/178.1, CONJUGATE OR COMPLEX OF MONOCLONAL OR POLYCLONAL ANTIBODY, IMMUNOGLOBULIN, OR FRAGMENT THEREOF WITH NONIMMUNOGLOBULIN MATERIAL530/391.7, Conjugated to a cytotoxic agent, drug, or other biologically-active substance530/391.9, Conjugated via a specifically-identified linking group, coupling agent, or conjugation agent530/868INVOLVING AUTOIMMUNITY, ALLERGY, IMMEDIATE HYPERSENSITIVITY, DELAYED HYPERSENSITIVITY, IMMUNOSUPPRESSION, OR IMMUNOTOLERANCEExaminersPrimary: Hazel, BlondelInternational ClassA61K 47/48 (20060101)AbstractConjugate composed of an oligonucleotide covalently bonded to a carrier.Other References
|
| ||||||||||||||
